Dan Pu

918 total citations
54 papers, 602 citations indexed

About

Dan Pu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Dan Pu has authored 54 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Dan Pu's work include Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Dan Pu is often cited by papers focused on Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Dan Pu collaborates with scholars based in China, United States and France. Dan Pu's co-authors include Yuwen Zhou, Jiyan Liu, Xuelei Ma, Yajuan Zhu, Liansha Tang, Qiang Wu, Yao Xie, Lu Li, Liyuan Yin and Qinghua Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Dan Pu

51 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Pu China 14 182 174 108 91 88 54 602
Francesco Cognetti Italy 12 288 1.6× 198 1.1× 87 0.8× 106 1.2× 95 1.1× 38 589
Yoon Hwan Chang South Korea 15 118 0.6× 241 1.4× 74 0.7× 83 0.9× 48 0.5× 66 618
Kurt R. Oettel United States 10 200 1.1× 150 0.9× 95 0.9× 133 1.5× 60 0.7× 25 545
Jun Xue China 14 72 0.4× 187 1.1× 84 0.8× 122 1.3× 109 1.2× 45 657
Yuli Wang China 14 195 1.1× 196 1.1× 71 0.7× 182 2.0× 114 1.3× 54 714
Jianwei Zhang China 18 261 1.4× 184 1.1× 98 0.9× 192 2.1× 238 2.7× 79 912
Kyoung Mee Kim South Korea 16 215 1.2× 202 1.2× 58 0.5× 179 2.0× 181 2.1× 40 653
Yuwen Zhou China 15 405 2.2× 213 1.2× 103 1.0× 194 2.1× 116 1.3× 53 868
Yong Lin China 17 92 0.5× 338 1.9× 93 0.9× 94 1.0× 84 1.0× 42 762
Hamid Asadzadeh‐Aghdaei Iran 15 93 0.5× 187 1.1× 63 0.6× 90 1.0× 123 1.4× 50 604

Countries citing papers authored by Dan Pu

Since Specialization
Citations

This map shows the geographic impact of Dan Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Pu more than expected).

Fields of papers citing papers by Dan Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Pu. The network helps show where Dan Pu may publish in the future.

Co-authorship network of co-authors of Dan Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Pu. A scholar is included among the top collaborators of Dan Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Pu. Dan Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jian, et al.. (2025). The Ketone Body β‐Hydroxybutyrate Mitigates the Ferroptosis of Alveolar Epithelial Cells Type II in Bleomycin‐Induced Pulmonary Fibrosis. The FASEB Journal. 39(15). e70920–e70920. 1 indexed citations
2.
Li, Yinghong, Yudong Yan, Mingze Bai, et al.. (2025). Efficient fine-tuning of small-parameter large language models for biomedical bilingual multi-task applications. Applied Soft Computing. 175. 113084–113084.
3.
Wang, Ting, Lu Li, Lin Huang, et al.. (2024). A phase II study of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8024–8024.
4.
Huang, Kai, Dan Pu, Ting Mei, et al.. (2024). Neoadjuvant chemoimmunotherapy in patients with limited-stage small cell lung cancer: A retrospective study.. Journal of Clinical Oncology. 42(16_suppl). e20002–e20002. 2 indexed citations
5.
6.
Pu, Dan, Yao Yao, Chuan Zhou, et al.. (2024). FMT rescues mice from DSS-induced colitis in a STING-dependent manner. Gut Microbes. 16(1). 2397879–2397879. 9 indexed citations
7.
Pu, Dan, et al.. (2023). Orthodontic Patients with Poor Oral Health-Related Quality of Life are More Likely to Have Emotional Distress: A Cross-Sectional Study. Patient Preference and Adherence. Volume 17. 3047–3056. 2 indexed citations
8.
Mu, Xiaoli, Dan Pu, Yajuan Zhu, et al.. (2023). Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study. Journal of Clinical Medicine. 12(12). 4126–4126. 1 indexed citations
9.
Liu, Lu, Dan Pu, Muhan Zhang, et al.. (2022). Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis. Frontiers in Pharmacology. 13. 905133–905133. 5 indexed citations
10.
11.
Yin, Liyuan, Wen Zhang, Dan Pu, et al.. (2022). Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis. Frontiers in Oncology. 11. 778549–778549. 4 indexed citations
12.
Pu, Dan, Zhe Zhang, & Bai–Sui Feng. (2022). Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Frontiers in Pharmacology. 13. 906419–906419. 19 indexed citations
13.
Pu, Dan, Liyuan Yin, Yuwen Zhou, et al.. (2021). Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer. Frontiers in Oncology. 11. 637504–637504. 69 indexed citations
14.
Zhou, Yuwen, Yao Xie, Liansha Tang, et al.. (2021). Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduction and Targeted Therapy. 6(1). 317–317. 81 indexed citations
15.
Xu, Hu, Hao Liu, Beiyu Wang, et al.. (2021). Cervical disc arthroplasty versus anterior cervical discectomy and fusion for the treatment of single-level disc degenerative disease with preoperative reversible kyphosis. Clinical Neurology and Neurosurgery. 202. 106493–106493. 9 indexed citations
16.
Zhou, Yuwen, Ruolan Xia, Dan Pu, et al.. (2020). Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer. International Immunopharmacology. 91. 107296–107296. 30 indexed citations
17.
Pu, Dan, et al.. (2020). CTLA-4 rs5742909 polymorphism and cervical cancer risk. Medicine. 99(11). e19433–e19433. 16 indexed citations
18.
Jiang, Yuting, Qian Lei, Yangping Wu, et al.. (2019). Potential Diagnostic and Prognostic Biomarkers of Circular RNAs for Lung Cancer in China. BioMed Research International. 2019. 1–17. 13 indexed citations
19.
Zhang, Li, Dan Pu, Dan Liu, et al.. (2019). Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer. Lung Cancer. 135. 130–137. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026